Maynard Um
-
-
-
-
-
-
-
Lexeo Therapeutics (LXEO) Reiterated at Overweight by Cantor Fitzgerald After Q4 Results
-
-
-
-
-
-
-
Raymond James Starts Lexeo Therapeutics (LXEO) at Strong Buy, PT $25
-
-
-
-
-
-
-
Lexeo Therapeutics (LXEO) PT Lowered to $13 at H.C. Wainwright
-
-
-
-
-
-
-
Oppenheimer Starts Lexeo Therapeutics (LXEO) at Outperform
-
-
-
-
-
-
-
Lexeo Therapeutics (LXEO) PT Lowered to $15 at H.C. Wainwright
-
-
-
-
-
-
-
Lexeo Therapeutics, Inc. (LXEO) Misses Q4 EPS by 6c
-
-
-
-
-
-
-
Lexeo Therapeutics (LXEO) PT Lowered to $21 at H.C. Wainwright
-
444,435 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

